• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Renal Resistive Index–Guided Blood Pressure Titration in Sepsis: Randomized Trial

Bioengineer by Bioengineer
July 17, 2026
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Sepsis care may be entering a more physiologic era, as researchers report results from a randomized controlled trial using renal resistive index (RRI) to guide mean arterial pressure (MAP) targets in critically ill patients. The study, published in Nature Communications, evaluated whether adjusting MAP according to Doppler-derived kidney hemodynamics could improve outcomes compared with standard fixed-pressure protocols.

Investigators enrolled participants in a prospective, single-center, single-blind, parallel-group design. The trial tested a strategy in which clinicians continually reassessed RRI at the bedside and titrated vasopressor therapy to reach an individualized MAP goal intended to optimize renal perfusion while avoiding unnecessary over-pressurization.

RRI, obtained through Doppler ultrasound, reflects downstream vascular resistance within the kidney. In practice, higher RRI values suggest impaired microvascular blood flow, prompting clinicians to consider raising MAP to restore perfusion. Conversely, lower RRI can signal that perfusion may already be adequate, potentially allowing MAP to be lowered to reduce risks associated with excessive vasopressor exposure.

The primary findings suggest that RRI-guided titration can meaningfully influence clinical trajectories in sepsis. By operationalizing a renal-specific hemodynamic indicator rather than relying solely on systemic blood pressure thresholds, the approach aims to align treatment with organ-level perfusion dynamics during a phase when sepsis pathophysiology fluctuates rapidly.

Mechanistically, the trial’s logic is straightforward: sepsis frequently disrupts the microcirculation, and kidneys are particularly vulnerable. Systemic MAP, while essential, does not always translate to consistent renal perfusion at the microvascular level. RRI offers a noninvasive window into that mismatch, enabling iterative bedside decision-making.

The team also emphasized feasibility. Doppler ultrasound assessments can be repeated serially, allowing titration protocols to adapt to changes in vascular tone, fluid status, and evolving organ dysfunction. In this trial setting, clinicians could integrate RRI readings into routine hemodynamic management without requiring invasive monitoring beyond standard critical care.

Beyond renal outcomes, the study reports broader clinical effects consistent with better-organ perfusion and potentially reduced progression to severe shock-related complications. These results support the concept that sepsis management should incorporate organ-targeted hemodynamic biomarkers alongside conventional vital sign targets.

If validated in larger multicenter studies, renal RRI guidance could refine international sepsis guidelines by introducing a measurable, kidney-focused endpoint for vasopressor titration. Such personalization may improve the balance between restoring perfusion and avoiding harm from overtreatment.

Overall, the work positions RRI as a practical biomarker candidate for precision hemodynamics in sepsis, turning an established Doppler parameter into a decision tool for MAP targets. The trial provides a compelling blueprint for future organ-directed monitoring strategies in critical care.

Subject of Research: Sepsis hemodynamic management using renal resistive index (RRI) to guide mean arterial pressure (MAP) titration.

Article Title: Renal resistive index-guided mean arterial pressure titration in sepsis: a prospective single-center, single-blind, parallel-group randomized controlled trial.

Article References: Wang, C., Li, R., Li, Q. et al. Renal resistive index-guided mean arterial pressure titration in sepsis: a prospective single-center, single-blind, parallel-group randomized controlled trial. Nat Commun (2026). https://doi.org/10.1038/s41467-026-75398-7

DOI: 10.1038/s41467-026-75398-7

Keywords: Renal resistive index; sepsis; mean arterial pressure; vasopressor titration; Doppler ultrasound; randomized controlled trial.

Tags: Doppler ultrasound in sepsisindividualized blood pressure controlkidney hemodynamics in critical illnessmean arterial pressure targetsmicrovascular renal perfusionorgan-specific hemodynamic monitoringpersonalized vasopressor therapyrenal perfusion in sepsisrenal resistive indexRRI-guided blood pressure titrationsepsis managementsepsis outcome optimization

Share12Tweet7Share2ShareShareShare1

Related Posts

Lurie Children’s Program Builds Pediatric Expertise to Treat More Youth Depression, Study Finds

July 17, 2026

CD33 and Clusterin Physically and Genetically Interact to Shape Alzheimer Risk

July 17, 2026

USF Study Finds Promising Strategy to Protect Hearts in Duchenne Muscular Dystrophy

July 17, 2026

Study Finds No Link Between Acetaminophen Use in Pregnancy and Birth Outcomes

July 17, 2026

POPULAR NEWS

  • Scientists Overcome Antimicrobial Resistance in Bacteria Linked to Cystic Fibrosis

    Scientists Overcome Antimicrobial Resistance in Bacteria Linked to Cystic Fibrosis

    42 shares
    Share 17 Tweet 11
  • Porcine Heart Transplant

    50 shares
    Share 20 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13
  • A multifaceted sensation

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blood DNA test better selects patients for prostate cancer radiopharmaceutical therapy

Surface-Enhanced Raman Enables Ultra-Sensitive Detection of Pb2+ Ions

Lurie Children’s Program Builds Pediatric Expertise to Treat More Youth Depression, Study Finds

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.